ATIMOX-CV 625 Tablets

Description

ATIMOX-CV 625 is a powerful combination antibiotic containing Amoxycillin and Clavulanic Acid, formulated to provide superior coverage against a wide range of bacterial infections. Clavulanate inhibits the β-lactamase enzyme, protecting Amoxycillin from degradation and restoring its full antimicrobial spectrum — even against resistant strains, including ESBL-producing bacteria.

This makes ATIMOX-CV 625 an effective and dependable option for the management of ENT, respiratory, skin, enteric, and urogenital infections.

Mechanism of Action

🔹 Amoxycillin Trihydrate (500 mg)

A broad-spectrum penicillin antibiotic effective against gram-positive and gram-negative bacteria.

🔹 Potassium Clavulanate (125 mg)

• Inhibits β-lactamase enzymes

• Restores the full antibacterial activity of Amoxycillin

• Extends coverage to resistant organisms

• Enhances overall treatment efficacy

Together, they provide resistance-free, bactericidal action for fast and effective infection control.

Key Benefits

✔ Protects Amoxycillin from β-lactamase degradation
✔ Effective against ESBL-producing bacterial strains
✔ Ensures broad-spectrum antimicrobial coverage
✔ Reliable clinical outcomes across various infections
✔ Fast relief with strong bactericidal action
✔ Ideal component in H. pylori combination therapy

Indications

ATIMOX-CV 625 is recommended in the management of:

• ENT Infections (otitis media, sinusitis, tonsillitis)

• Respiratory Tract Infections (bronchitis, pneumonia)

• Urogenital Infections

• Skin and Soft Tissue Infections

• Enteric Infections

• As part of therapy for H. pylori infection

Dosage Form

Tablet
Composition: Amoxycillin 500 mg + Clavulanate 125 mg
Brand: ATIMOX-CV 625

The Key to Success Against Resistant Infections!